14.49% 0.0549

Harvard Bioscience Inc (HBIO)

概要ニュース株価時系列オプションチェーン Financials ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Harvard Bioscience Inc Stock (HBIO) Company Profile

Harvard Bioscience Inc

Healthcare (1170)

(508) 893-8999

84 OCTOBER HILL RD, HOLLISTON, MA

HBIO's Discussions on Twitter

HBIO を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
HBIO Harvard Bioscience Inc	0.4599	20.22M	106.79M	-8.73M	10.81M	-0.20
ISRG Intuitive Surgical Inc	514.89	189.29B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	179.10	50.30B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	86.52	43.02B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	256.64	37.53B	5.02B	1.31B	1.56B	8.91
WST West Pharmaceutical Services Inc	223.70	16.25B	2.90B	467.20M	306.90M	6.37

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2025-04-09	ダウングレード	KeyBanc Capital Markets	Overweight → Sector Weight
2023-03-10	アップグレード	The Benchmark Company	Speculative Buy → Buy
2021-01-07	アップグレード	The Benchmark Company	Speculative Buy → Buy
2020-12-09	開始されました	Northland Capital	Outperform
2020-11-10	開始されました	KeyBanc Capital Markets	Overweight
2019-07-08	ダウングレード	Janney	Buy → Neutral
2018-01-24	繰り返されました	Janney	Buy
2018-01-23	繰り返されました	The Benchmark Company	Buy
2016-11-17	開始されました	Singular Research	Buy
2015-07-28	開始されました	The Benchmark Company	Buy

Harvard Bioscience Inc (HBIO) 最新ニュース

Harvard Bioscience Inc (HBIO) 財務データ

Harvard Bioscience Inc (HBIO)

Harvard Bioscience Inc Stock (HBIO) Company Profile

HBIO を他の銘柄と比較する

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Harvard Bioscience Inc (HBIO) 最新ニュース

Harvard Bioscience Announces CEO Succession Plan - TipRanks

Harvard Bioscience names John Duke as new CEO as Jim Green retires - Investing.com

Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board - GlobeNewswire

Harvard Bioscience Taps Growth Expert as New CEO: Former Corning Executive Brings 20% Annual Growth Record - Stock Titan

How Harvard Bioscience Inc. stock performs during market volatilitySafe and Scalable Investment Tips - Newser

What makes Harvard Bioscience Inc. stock price move sharplyBreakout Confirmation Tool - Newser

Why Harvard Bioscience Inc. stock attracts strong analyst attentionFast Growing Stocks - Newser

Harvard Bioscience (NASDAQ:HBIO) versus Electronic Sensor Technologies (OTCMKTS:ESNR) Financial Comparison - Defense World

Is Harvard Bioscience, Inc. technically bullish or bearish? - MarketsMojo

Harvard Bioscience falls out of Nasdaq compliance after board member resignation - Worcester Business Journal

Harvard Bioscience Faces Nasdaq Compliance Challenge - TipRanks

HBIO gets Nasdaq notice over audit committee vacancy, cure plan in place | HBIO SEC FilingForm 8-K - Stock Titan

Financial Fitness Check: Examining Harvard Bioscience Inc (HBIO)’s Key Ratios - DWinneX

Major Improvements In Harvard Bioscience Inc (HBIO) Stock Need To Be Considered - Stocksregister

Harvard Bioscience appoints new board member as director steps down - Worcester Business Journal

What Did We Find About Insider Trading At Harvard Bioscience Inc (NASDAQ: HBIO)? - Stocksregister

Harvard Bioscience Appoints John Duke to Board of Directors - The Manila Times

Harvard Bioscience appoints new board member By Investing.com - Investing.com South Africa

Harvard Bioscience Approves Incentive Plan Amendment - TipRanks

Harvard Bioscience appoints new board member - Investing.com

Harvard Bioscience Appoints John Duke to Board of Directors | HB - GuruFocus

Harvard Bioscience Strengthens Board with Ex-Corning Life Sciences Leader John Duke, Names New Lead Director - Stock Titan

Little Excitement Around Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Revenues As Shares Take 26% Pounding - simplywall.st

Harvard Bioscience First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Harvard Bioscience price target lowered to $3 from $4.50 at Benchmark - Yahoo Finance

Harvard Bioscience outlines Q2 revenue target of $18M–$20M amid product launches and cost actions - MSN

Harvard Bioscience (HBIO): Analyst Lowers Price Target, Maintains Rating | HBIO Stock News - GuruFocus

Harvard Bioscience (HBIO) Target Price Reduced Amid Market Challenges | HBIO Stock News - GuruFocus

Harvard Bioscience (HBIO) Target Price Reduced Amid Market Chall - GuruFocus

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2025 Earnings Call Transcript - Insider Monkey

Harvard Bioscience Inc (HBIO) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Innovations - GuruFocus

Earnings call transcript: Harvard Bioscience Q1 2025 revenue beats forecast By Investing.com - Investing.com South Africa

Harvard Bioscience Announces First Quarter 2025 Financial Results - GlobeNewswire

Harvard Bioscience: Q1 Earnings Snapshot - MySA

Harvard Bioscience (HBIO) Reports Q1 2025 Highlights Amid Financ - GuruFocus

Harvard Bioscience Q1 2025 Earnings Call Transcript - MarketBeat

Transcript : Harvard Bioscience, Inc., Q1 2025 Earnings Call, May 12, 2025 - marketscreener.com

Harvard Bioscience earnings matched, revenue topped estimates By Investing.com - Investing.com Canada

HBIO Reports Decline in Q1 Revenue Amid Market Challenges | HBIO Stock News - GuruFocus

Harvard Bioscience earnings matched, revenue topped estimates - Investing.com

Harvard Bioscience Inc reports results for the quarter ended March 31Earnings Summary - TradingView

Harvard Bioscience, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:HBIO) - Seeking Alpha

Harvard Bioscience Q1 2025 slides: Revenue decline and goodwill impairment weigh on results - Investing.com Canada

Earnings call transcript: Harvard Bioscience Q1 2025 revenue beats forecast - Investing.com

Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

Harvard Bioscience Inc Reports Q1 2025 Revenue of $21.8M, Exceed - GuruFocus

Harvard Bioscience Inc (HBIO) 財務データ

収益

当期純利益

現金流量

EPS

HBIOに似た銘柄